Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer

MLA

Jennifer Thomas, et al. “Building on the Anti-PD1/PD-L1 Backbone: Combination Immunotherapy for Cancer.” Expert Opinion on Investigational Drugs, vol. 28, no. 8, July 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e973298ebc86f4ecf6359aa7e3701c39&authtype=sso&custid=ns315887.

APA

Jennifer Thomas, Lewis Au, James Larkin, Alvaro Henrique Ingles Garces, & Robert Mason. (2019). Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer. Expert Opinion on Investigational Drugs, 28(8).

Chicago

Jennifer Thomas, Lewis Au, James Larkin, Alvaro Henrique Ingles Garces, and Robert Mason. 2019. “Building on the Anti-PD1/PD-L1 Backbone: Combination Immunotherapy for Cancer.” Expert Opinion on Investigational Drugs 28 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e973298ebc86f4ecf6359aa7e3701c39&authtype=sso&custid=ns315887.